Here, we found that IL-6 could inhibit the upregulation of TGFβRI mediated by TGF-β in vitro, and the plasma IL-6 levels in SLE patients were significantly elevated but negatively correlated with TGFβRI mRNA level. The gene discussed is TGFB1; the disease is systemic lupus erythematosus.